Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo(®) 200) in the treatment of Parkinson’s disease: a case series

Levodopa continues to be the most efficacious and widely used treatment for Parkinson’s disease. Levodopa dosing is understood to be critical for the optimal control of symptoms, and increasing the levodopa dose is a common method to treat advancing disease. Escalating levodopa dosages coupled with...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sethi, Kapil D, Hauser, Robert A, Isaacson, Stuart H, McClain, Terry
Médium: Artigo
Jazyk:Inglês
Vydáno: Cases Network Ltd 2009
Témata:
Case report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2740140/
https://ncbi.nlm.nih.gov/pubmed/19829918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4076/1757-1626-2-7134
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky